Kyungdong Pharmaceutical's Key Executives Purchase Company Shares... "Part of Responsible Management"

[Asia Economy Reporter Park Hyungsoo] Kyungdong Pharmaceutical announced on the 3rd that key executives, including Chief Financial Officer (CFO) Kim Kyunghun, purchased company shares.

CFO Kim Kyunghun, Director Seo Youngdeok, and Director Oh Dongil purchased 11,300 shares of the company on the 21st through on-market transactions. The total number of shares purchased by key executives this year amounts to 14,500 shares.

A company representative stated, "The purchase of company shares by key executives was carried out under the judgment that the stock price is undervalued, demonstrating a commitment to responsible management," and added, "We will continue to implement shareholder-friendly policies such as share repurchases and dividend expansions." They also added, "We will achieve sustainable growth by expanding investments in bio-venture companies."

Kyungdong Pharmaceutical is expanding its investments in bio-venture companies to secure new growth engines. Last month, it decided to invest 2 billion KRW in equity in AULBIO, a venture company developing long-acting biopharmaceuticals. The company plans to strengthen strategic partnerships with AULBIO, which possesses outstanding technology in drug delivery, to create synergy effects.

This content was produced with the assistance of AI translation services.